Members’ Meeting: State of the Union – Late Stage Financing – Crossover & IPOs

starts:27/02/2019 ends:27/02/2019 from:14:30 to:18:00 address:Novo Holdings, Tuborg Havnevej 19, 2900 Hellerup mobile:+4551500560 email: dd@danskbiotek.dk www: Link >> price:Free of charge for the members, Non members: 500 DKK Import to calendar
adresse:
Novo Holdings, Tuborg Havnevej 19, 2900 Hellerup
Get directions

Program

  • 14:30
    Registration and networking
  • 15:00
    Welcome by Søren Møller, Board Member, DANSK BIOTEK
  • 15:00
    The big picture – A global economy perspective by Jeppe Christiansen, CEO, Maj Invest
  • 15:30
    Opportunities for crossover investments in Europe by Tom Burt, Partner, Sofinnova Crossover Fund
  • 16:00
    Recent public/late stage examples
  • • Peter Nordkild, CEO, Asarina Pharma on IPO financing (SE)
  • • Thomas H. Pedersen, CEO, NMD Pharma on VC financing
  • 16:45
    Climate for later stage funding in Europe - Panel discussion chaired by Søren Møller, Novo Holdings, and Anders Hinsby, Orphazyme A/S
  • 17:30
    Networking and snacks
  • DANSK BIOTEK Members' Meeting 27 Feb 2019

Venue: Novo Holdings, Tuborg Havnevej 19, 2900 Hellerup

Date: 27/02/2019

Time: 14:30 - 18:00

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2019 Danskbiotek. All rights reserved.